ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2495

Dense Genotyping of Candidate Genes Identifies 16 New Susceptibility Loci in Ankylosing Spondylitis

Adrian Cortes1, Philip Robinson1, International Spondyloarthritis Genetics Consortium2 and Matthew A. Brown1, 1Human Genetics Group, The University of Queensland Diamantina Insititute, Brisbane, Australia, 2Brisbane, Australia

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS) and genetic disorders

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthritis and Psoriatic Arthritis - Pathogenesis, Etiology

Session Type: Abstract Submissions (ACR)

Background/Purpose: Ankylosing spondylitis (AS) is a highly heritable inflammatory arthritis common in both Asian and European populations. Thus far genes identified include the HLA-B*27 allele, and 13 non-MHC loci identified in European populations. In this study we aimed to better characterize the genetic architecture of AS and to fine-map known susceptibility loci.

Methods: We successfully genotyped 129,030 polymorphic SNPs in 10,624 AS affected and 15,174 healthy individuals of European and Asian descent using the  Illumina Immunochip microarray, which designed for immunogenetic studies.

Results: In this study we identified 16 new AS risk loci reaching genome-wide significance (P< 5x10-8), bringing the number of known non-MHC loci to 27. All attempted genome-wide significant loci reported in European populations were replicated.  We found multiple independent association signals in 8 of these loci, caused by both common and low frequency variants, suggesting that multiple genetic variants within a gene can affect disease susceptibility. Three AS-loci encoding four aminopeptidases were identified which are involved in peptide handling prior to MHC Class I presentation; protective variants at two of these are associated with both reduced aminopeptidase function and MHC Class I cell surface expression. European and Asian specific signals were observed in IL23R and PTGER4. Identified loci implicate microbial sensing (NOS2, NKX2-3, SH2B3 and ICOSLG), intracellular antigenic peptide handling (ERAP1, ERAP2, LNPEP, NPEPPS) and CD8+ T cells (EOMES and IL7R) pathways as important in AS etiology as well as increase the number of susceptibility genes in the TH17 pathway (TYK2 and IL6R). A second MHC association with the classical HLA-A*0201 was observed in both HLA-B*27 positive and negative disease (OR=1.2; P= 4.5 × 10-9).

Conclusion: This increased characterization of the genetic architecture of AS aids greatly in explaining the currently poorly understood high observed heritability and familiality in AS. This data also guides functional studies towards uncovering how these genes cause disease and in the development of new therapeutics.


Disclosure:

A. Cortes,
None;

P. Robinson,
None;

M. A. Brown,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dense-genotyping-of-candidate-genes-identifies-16-new-susceptibility-loci-in-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology